Scientists uncover immune cell secrets in kidney disease
NCT ID NCT06994468
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 30 times
Summary
This study looked at 48 people with membranous nephropathy, a kidney disease, to see how treatments that deplete B-cells affect specific immune cells linked to the condition. Researchers measured these cells before and after therapy to understand why some patients get better long-term while others relapse or don't respond. The goal was to learn more about the disease process, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEMBRANOUS NEPHROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Research Centre for Rare Diseases Aldo e Cele Daccò
Ranica, BG, 24020, Italy
Conditions
Explore the condition pages connected to this study.